These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10327529)

  • 21. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.
    Mayaux MJ; Dussaix E; Isopet J; Rekacewicz C; Mandelbrot L; Ciraru-Vigneron N; Allemon MC; Chambrin V; Katlama C; Delfraissy JF; Puel J
    J Infect Dis; 1997 Jan; 175(1):172-5. PubMed ID: 8985214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method.
    Chouquet C; Burgard M; Richardson S; Rouzioux C; Costagliola D
    AIDS; 1997 Jul; 11(9):1183-4. PubMed ID: 9233467
    [No Abstract]   [Full Text] [Related]  

  • 23. Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso.
    Prazuck T; Yameogo JM; Heylinck B; Ouedraogo LT; Rochereau A; Guiard-Schmid JB; Lechuga P; Agranat P; Cot M; Malkin JE
    Pediatr Infect Dis J; 1995 Nov; 14(11):940-7. PubMed ID: 8584359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
    Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
    JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
    ; Andiman W; Bryson Y; de Martino M; Fowler M; Harris D; Hutto C; Korber B; Kovacs A; Landesman S; Lindsay M; Lapointe N; Mandelbrot L; Newell M-L; Peavy H; Read J; Rudin C; Semprini A; Simonds R; Tuomala R
    N Engl J Med; 1999 Apr; 340(13):977-87. PubMed ID: 10099139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A survey of children with HIV/AIDS in highly epidemic villages of AIDS].
    Zhuang K; Gui XE; Luo JL; Wang XR; Su B; Zhang YX
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):586-9. PubMed ID: 14744378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission.
    Sanborn KB; Somasundaran M; Luzuriaga K; Leitner T
    Retrovirology; 2015 Nov; 12():96. PubMed ID: 26573574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.
    Rouet F; Sakarovitch C; Msellati P; Elenga N; Montcho C; Viho I; Blanche S; Rouzioux C; Dabis F; Leroy V;
    Pediatrics; 2003 Oct; 112(4):e289. PubMed ID: 14523214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda.
    Lepage P; Van de Perre P; Msellati P; Hitimana DG; Simonon A; Van Goethem C; Mukamabano B; Karita E; Stevens AM; Mathieu G
    Am J Epidemiol; 1993 Mar; 137(6):589-99. PubMed ID: 8470660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
    Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
    Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G; Mary JY; Coeur SL; Ngo-Giang-Huong N; Yuthavisuthi P; Limtrakul A; Traisathit P; McIntosh K; Lallemant M;
    J Infect Dis; 2007 Dec; 196(11):1629-36. PubMed ID: 18008246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of mother-to-infant HIV transmission in tribal women from India.
    Kumar RM; Uduman SA; Khurranna AK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):238-42. PubMed ID: 7788422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
    Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjusting for time-dependent sensitivity in an illness-death model, with application to mother-to-child transmission of HIV.
    Teeple EA; Brown ER
    Stat Med; 2015 Apr; 34(8):1277-92. PubMed ID: 25546029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission.
    Biggar RJ; Miotti PG; Taha TE; Mtimavalye L; Broadhead R; Justesen A; Yellin F; Liomba G; Miley W; Waters D; Chiphangwi JD; Goedert JJ
    Lancet; 1996 Jun; 347(9016):1647-50. PubMed ID: 8642957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
    Tubiana R; Le Chenadec J; Rouzioux C; Mandelbrot L; Hamrene K; Dollfus C; Faye A; Delaugerre C; Blanche S; Warszawski J
    Clin Infect Dis; 2010 Feb; 50(4):585-96. PubMed ID: 20070234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission.
    Guay LA; Hom DL; Mmiro F; Piwowar EM; Kabengera S; Parsons J; Ndugwa C; Marum L; Olness K; Kataaha P; Jackson JB
    Pediatrics; 1996 Sep; 98(3 Pt 1):438-44. PubMed ID: 8784370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe.
    Zijenah LS; Moulton LH; Iliff P; Nathoo K; Munjoma MW; Mutasa K; Malaba L; Zvandasara P; Ward BJ; Humphrey J;
    AIDS; 2004 Jan; 18(2):273-80. PubMed ID: 15075545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.